Capsugel® DRcaps® capsules offer nutritional supplement makers a dosage form with outstanding consumer and manufacturing appeal. Some of the most common applications are for probiotics and enzymes. Pharmaceutical companies have also expressed interest in Capsugel® DRcaps® capsules for APIs which require some level of delayed release properties. Lonza developed a novel pharmaceutical modified-release technology named Vcaps® Enteric. Vcaps® Enteric are truly enteric and comply with the USP definition of enteric release.